BX 471

Drug Profile

BX 471

Alternative Names: BAY 865047; CCR1 - Bayer Healthcare; CCR1 antagonist - Bayer Healthcare; SH T 04268H; ZK-811752

Latest Information Update: 21 Mar 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bayer HealthCare Pharmaceuticals
  • Developer Bayer HealthCare Pharmaceuticals Inc.
  • Class Phenylurea compounds; Piperidines; Radiopharmaceutical diagnostics; Small molecules
  • Mechanism of Action CCR1 receptor antagonists; Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Alzheimer's disease; Endometriosis; Multiple myeloma; Multiple sclerosis; Psoriasis

Most Recent Events

  • 01 Mar 2011 Bayer Schering Pharma is now called Bayer Healthcare Pharmaceuticals
  • 04 Apr 2007 Berlex Inc has been acquired by Bayer HealthCare (MR 9074204)
  • 29 Dec 2006 Schering AG is now called Bayer Schering Pharma
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top